Analyst rating changes, price target updates, and coverage initiations with technical context including 52-week range positioning and price momentum.
CrowdStrike Holdings received a broad sweep of analyst reaffirmations today, with 10 out of 12 firms confirming a "buy" rating and an average price target of approximately $242 across all actions. Despite the analyst support, CRWD shares are trading at $216.47, down 5.04% on the session, creating a
Salesforce, Inc. (CRM) surged 22.46% to $252.25 on Friday as a wave of analyst reaffirmations and price target increases swept across Wall Street, with Needham maintaining the most bullish outlook at a $400 price target. The stock's jump puts it squarely in the upper half of its 52-week range of $14
A wave of analyst reaffirmations swept across Wall Street on Thursday, August 27, 2026, as 11 firms confirmed buy ratings on NVIDIA Corporation, with an average price target of $361.45 and targets ranging as high as $515 from Raymond James. NVDA shares surged 8.64% to $227.77 on the session, a move
CrowdStrike Holdings, Inc. is having a standout Thursday, with shares surging 17.72% to $222.70 as a wave of 12 analyst actions hit the tape, reinforcing broad institutional conviction in the cybersecurity giant. Ten of those actions carry buy-equivalent ratings, with an average price target of $242
RBC Capital analyst Piral Dadhania reaffirmed a "Hold" rating on Nike, Inc. (NKE) on Thursday, August 27, keeping the price target unchanged at $45. The confirmation comes with NKE trading at $38.595, nearly flat on the session, and hovering just above its 52-week low of $38.4137, well below the 52-
V market update based on latest analyst_update data.
Salesforce, Inc. (CRM) is making a strong move Wednesday, climbing 12.33% to $231.06 after two analyst firms reaffirmed their buy ratings on the stock, keeping price targets intact. Citizens analyst Patrick Walravens maintained his buy rating with a $315 price target, while Canaccord Genuity's David
Wolfe Research analyst Darrin Peller has reaffirmed a Buy rating on Mastercard Incorporated while lifting the price target to $740 from a prior $680, implying meaningful upside from the stock's current price of $597.83. The confirmation comes with MA trading near the top of its 52-week range of $464
RBC Capital analyst Piral Dadhania reaffirmed a "Hold" rating on Nike, Inc. with an unchanged price target of $45, offering little relief for a stock already trading near multi-year lows. NKE currently sits at $39.45, down 0.08% on the session, and is trading dangerously close to its 52-week low of
Argus Research analyst Jasper Hellweg reaffirmed a buy rating on Merck and Company, Inc. while lifting the price target from $145 to $170, implying meaningful upside from the current price of $153.73. The confirmation arrives as MRK trades near the top of its 52-week range of $77.58 to $154.49, just
Merck & Company shares are pushing to within striking distance of their 52-week high of $153.47 on Friday, climbing 2.27% to $152.57 after a wave of analyst activity headlined by a bold upgrade from Morgan Stanley. Analyst Terence Flynn lifted his rating to "buy" and dramatically raised his pric
The forward setup for AbbVie looks constructive heading into the back half of 2026. The stock's proximity to its 52-week high of $267.47 makes a clean breakout the key technical event to watch. A decisive move above that level, supported by analyst confidence reflected in the Piper Sandler target ra
Merck & Company, Inc. received a split verdict from Wall Street on Thursday, with Morgan Stanley analyst Terence Flynn upgrading the stock to "buy" and raising his price target dramatically to $179 from a prior $116, while RBC Capital's Trung Huynh simultaneously downgraded shares to "hold" with a m
Citigroup analyst Tyler Radke confirmed a Hold rating on Salesforce, Inc. (CRM) on Wednesday while raising the price target from $187 to $204, a move that coincides with a strong single-session gain of 5.11%. Shares are currently trading at $206.17, which now sits fractionally above the newly issued
CrowdStrike Holdings, Inc. is under significant selling pressure Wednesday, dropping 5.79% to $200.59, even as three Wall Street firms simultaneously confirmed buy ratings and raised their price targets on the cybersecurity giant. Barclays, Benchmark, and TD Cowen all lifted their targets, with the
Cisco Systems (CSCO) is under heavy selling pressure Thursday, dropping 9.43% to $112.20, yet four Wall Street firms have responded by raising their price targets on the stock rather than retreating. The average price target across all four updated calls now stands at $146.25, representing significa
The forward setup for MRK is constructive from a technical and sentiment standpoint. A confirmed buy rating from Argus Research, paired with a price target that clears the prior 52-week high, gives the stock a defined upside objective heading into the back half of the year. The 2.40% gain on Wednesd
Evercore Partners analyst Kirk Materne confirmed a Buy rating on Snowflake Inc. while significantly raising the price target to $360 from a prior $280, representing a $80 increase in the firm's valuation outlook. SNOW is currently trading at $335, up a modest 0.09% on the session, and sits near the
Wells Fargo analyst Ken Gawrelski reaffirmed a Buy rating on Meta Platforms, Inc. and nudged his price target up to $767 from $765, even as META shares tumbled 5.03% to $582.05 on Friday, July 3. The vote of confidence from Wells Fargo arrives at a turbulent moment, with the stock sitting well below
Tesla shares are under significant pressure today, falling 7.23% to $394.54 as three analyst firms simultaneously reaffirmed their hold ratings on the stock, with an average price target of $421.67 that sits just modestly above the current price. The convergence of cautious analyst sentiment on a ho